In conclusion, we herein show for the first time that the lncRNA, FAM215A, is highly expressed in HCC, where it interacts with and prevents the ubiquitination of LAMP2 to increase tumor progression and decrease doxorubicin sensitivity. The gene discussed is FAM215A; the disease is hepatocellular carcinoma.